Form 4 Filing for ADIAL PHARMACEUTICALS, INC.

This filing details a Form 4 submission for ADIAL PHARMACEUTICALS, INC. by reporting owner Tony Goodman, who holds the positions of Chief Operating Officer and Director. On April 7, 2026, Mr. Goodman was granted 26,510 restricted shares of common stock. These shares vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control, provided Mr. Goodman remains in continuous service to the Issuer. The shares were granted at a price of $0.0 per share. Following this transaction, Mr. Goodman owns 26,523 shares of common stock.